Need of an Ancient Roots to Modern Medicine in the Treatment of Cancer- A review
Keywords:
Photochemical, Cell cycle, Cytotoxic, Cytostatic, Drug resistanceAbstract
The already available expensive conventional therapies for cancer like chemotherapy and radiotherapy have a number of side effects such as myelosuppression and neurological, cardiac, pulmonary, and renal toxicity, which pose serious harm to the quality of life. Therefore, there is a need to develop treatment options that include more potent and less toxic anticancer drugs as compared to existing drugs. Studies have shown that regular consumption of fruits and vegetables because of phytochemical compounds extracted from them inhibiting the activity of antioxidant and free radicals which in turn showing anti-cancer activities. More recent semi-synthetic analogues of these agents are vinorelbine (VRLB) and vindesine (VDS). These agents are primarily used in combination with other cancer chemotherapeutic drugs for the treatment of a variety of cancers. VLB is used for the treatment of leukaemia, lymphomas, advanced testicular cancer, breast and lung cancers, and Kaposi’s sarcoma, and VCR, in addition to the treatment of lymphomas, also shows efficacy against leukaemia, particularly acute lymphocytic leukaemia in childhood. VRLB has shown activity against non-small-cell lung cancer and advanced breast cancer. Therefore there is need of developing cell cycle-based, mechanism-targeted ancient based modern cancer therapies that emulate the body's natural process in order to stop the growth of cancer cells. This approach can limit the damage to normal cells and the accompanying side effects caused by conventional chemotherapeutic agents. This review focuses on the role of ancient medicine in modern research and anticancer drug development. The current findings and known anticancer agents from natural sources are discussed, and recent therapeutic advances in this field are presented.
References
. Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E. Natural compounds for
cancer treatment and prevention.
Pharmacology Research. 59(6):365-78.
. Jena J. (2012). A Study on Natural
Anticancer Plants. International Journal
Pharmaceutical Chemical Sciences;
(2009). 1(1):365-8.
. Dhorajiya BD, Patel JR, Malani MH,
Dholakiya BZ. Plant product (R)-
Roscovitine valuable inhibitor of CDKs
as An anti-cancer agent. Der
Pharmacia Sinica (2012). 3(1):131-43.
. Jena J. A Study on Natural Anticancer
Plants. International Journal
Pharmaceutical Chemical Sciences;
(2012) .1(1):365-8.
. Lee KH. Human medicinal agents from
plants. In: Kinghorn AD, Balandrin M,
editors. ACS Symposium Series No.
Washington, DC: American
Chemical Society; Chap. (1993). 12
. Mitchison TJ. The proliferation rate
paradox in antimitotic chemotherapy.
Molecular Biology Cell; (2012). 23: 1–6.
. Sparreboom A, de Jonge MJ, Verweij
J. The use of oral cytotoxic and
cytostatic drugs in cancer treatment.
European Journal Cancer; (2002). 38:
-22.
. Mihlon F, Ray CE, Messersmith W.
Chemotherapy Agents. A Primer for the
Interventional Radiologist. Semin
Intervention Radiology; (2010). 27:
–390.
. Akerele O. Fitotrepia, 1988, 59, 355-
. Srinivas K, Afolayan AJ. Current
Science, (2007). 92, 906-8.
. American Cancer Society, A
biotechnology company dedicated to
cancer treatment, viewed on 25th Jan.
;
www.cancer.vax.com/info/indexhtm.
. Kathiresan K. Boopathy N.S Kavitha
S. Natural Product Radience(2006). 5,
-19.
. Meyer JJM , Taylor MB. Journal of
Ethnopharmacology, (1996). 52, 41-43.
. Madhuri S, Pandey G. Plant Archives,
(2008). 8, 13-16.
. Sivalokanathan S, Ilayaraja M. Indian
Journal of Experimental Biology, (2005)
, 264-67.
. Belayachi L, Aceves-Luquero C,
Merghoub N, Bakri Y, de Mattos SF,
Amzazi S, Villalonga P. Screening of
North African medicinal plant extracts
for cytotoxic activity against tumor cell
lines. European Journal Medicinal
Plants (2013).3: 310–332.
. Saklani A, Kutty SK. Plant-derived
compounds in clinical trials. Drug
Discovery Today (2008). 13: 161–171.
. Nema R, Khare S, Jain P, Pradhan A,
Gupta A, Singh D. Natural products
potential and scope for modern cancer
research. American Journal Plant
Science (2013). 4: 1270–1271.
. Alonso-Castro AJ, Villarreal ML,
Salazar-Olivo LA, Gomez-Sanchez M,
Dominguez F, Garcia-Carranca A.
Mexican medicinal plants used for
cancer treatment: Pharmacological,
phytochemical and ethnobotanical
studies. Journal of
Ethnopharmacology (2011).133: 945–
. Gordaliza M. Natural products as
leads to anticancer drugs. Clinical and
Translational Oncology (2007). 9:
–776.
. Gerson-Cwilich R, Serrano-Olvera A,
Villalobos-Prieto A. Complementary
and alternative medicine (CAM) in
Mexican patients with cancer. Clinical
and Translational Oncology (2006). 8:
–207.
. Tascilar M, De Jong FA, Verweij J,
Mathijssen RH Complementary and
alternative medicine during cancer
treatment: beyond innocence.
Oncologist (2006). 11: 732–741.
. Akter R, Uddin SJ, Grice ID, Tiralongo
D. Cytotoxic activity screening of
Bangladeshi medicinal plant extracts.
Journal of Natural Medicines (2014).68:
–252.
. Cassileth BR, Deng G.
Complementary and alternative
therapies for cancer. Oncologist
(2004). 9: 80–89. RAINA et al. / Turk J
Bot 1034.
. Molassiotis A, Panteli V, Patiraki E,
Ozden G, Platin N, Madsen E, Browall
M, Fernandez Ortega P, Pud D,
Margulies A . Use of complementary
and alternative medicine in cancer
patients: a European survey. Annals of
Oncology. (2006). 16(4):655-63.
. Feng Y, Wang N, Zhu M, Feng Y., Li
H., Tsao S. Recent Progress on
Anticancer Candidates in Patents of
Herbal Medicinal Products Recent
Patents on Food, Nutrition and
Agriculture, 2011, 3, 30-48
. Safarzadeh E, Sandoghchian S,
Baradaran B. Herbal medicine as
inducers of apoptosis in cancer
treatment. Advanced Pharmaceutical
Bulletin (2014) .4: 421-427.
. Pal SK, Shukla Y. Herbal medicine:
current status and the future. Asian
Pacific Journal Cancer Prevention
(2003) .4: 281-288.
. Koehn FE, Carter GT. The evolving
role of natural products in drug
discovery. National Reviews Drug
Discovery (2005).4: 206-220.
. Saklani A, Kutty SK. Plant-derived
compounds in clinical trials. Drug
Discovery Today (2008) ;13: 161-171.
. Wang CZ, Calway T, Yuan CS. Herbal
medicines as adjuvants for cancer
therapeutics. American Journal of
Chinese Medicine (2012);40: 657-669.
. Kumar DR, George VC, Suresh PK,
Kumar RA. Cytotoxicity, apoptosis
induction and anti-metastatic potential
of Oroxylum indicum in human breast
cancer cells. Asian Pacific Journal and
Cancer Prevention (2012);13: 2729-
. Wang Z, Wang N, Chen J, Shen J.
Emerging glycolysis targeting and drug
discovery from chinese medicine in
cancer therapy. Evidence Based
Complement Alternative Medicine
(2012).
. Mukherjee AK, Basu S, Sarkar N,
Ghosh AC. Advances in cancer therapy
with plant based natural products.
Current Medical Chemistry (2001);8:
-1486.
. Ravindranath MH, Muthugounder S,
Presser N, Viswanathan S. Anticancer
therapeutic potential of Soy isoflavone
genistein. In Complementary and
Alternative Approaches to Biomedicine,
Springer, US, (2004) ; 121-165.
. Liu RH. Potential synergy of
Phytochemicals in cancer prevention,
mechanism of action. Journal of
Nutrition (2004);134: 3479S-3485S.
. Kumar RA, Sridevi K, Kumar NV,
Nanduri S, Rajagopal S. Anticancer
and immunostimulatory compounds
from Andrographis paniculata. Journal
of Ethnopharmacology (2004); 92:
-295.
. Mothana R, Grunert R, Lindequist U,
Bednarski PJ. Study of the anticancer
potential of Yemeni plants used in folk
medicine. Pharmazie (2007); 62: 305-
. God JM, Tate P, Larcom LL.
Anticancer effects of four varieties of
muscadine grape. Medicinal Food
(2007);10: 54-59.
. Zhang H, Wang X, Chen F,
Androulakis XM, Wargovich MJ.
Anticancer activity of limonoid from
Khaya senegalensis. Phytotherapy
Research (2007);21: 731-734.
. Widodo N, Kaur K, Shrestha BG,
Takagi Y, Ishii TSelective killing of
cancer cells by leaf extract of
Aswagandha: identification of a
tumour-inhibitory factor and the first
molecular insights to its effects. Clinical
Cancer Research .(2007);13: 2298-
. Wang SY, Feng R, Bowmank L, Lu Y,
Ballington JR. Antioxidant activity of
Vaccinium stamineum;exhibition of
anticancer capability in human lung
and leukemia cells. Planta Medicina
(2007);53: 451-460.
. Neto CC. Cranberry and its
phytochemicals:a review of in vitro
anticancer studies. Journal of Nutrition
(2007);137: 186S-193S.
. Wang MY, Su C. Cancer preventive
effect of Morinda citrifolia. Academic
Science (2001); 952: 161-168.
. Guruvayoorappan C, Kuttan G.
Immunomodulatory and antitumour
activity of Biophytum senstivium
extract. Asian Pacific Journal and
Cancer Prevention (2007);8: 27-32.
. Ferguson PJ, Kurowska EM, Freeman
DJ, Chambers AF, Koropatnick J.
Invivo inhibition of growth of human
tumour lines by flavanoid from
cranberry extract. Nature Reviews
Cancer (2006);56: 86-94.
. Roy MK, Kobori M, Takenaka M,
Nakahara K, Shinmoto H.
Antiproliferative effect on human
cancer cell lines after treatment
nimbolide extracted from an edible part
of the neem tree. Phytotherapy
Research (2007);21: 245-250.
. Arulkumaran S, Ramprasath VR,
Shanthi P, Sachdanandam P.
Restorative effect of Kalpaamrutha, an
indigenous preparation, an oxidative
damage in mammary gland
mitochondrial fraction in experimental
mammary carcinoma. Molecular Cell
Biochemistry (2006);291: 77-82.
. Amirghofran Z, Bahmani H, Azadmehr
A, Javidnia K. Induction of apoptosis in
leukemia cell lines by Linum persicum
and Euphorbia cheiradenia. Journal
Cancer Research and Clinical
Oncology (2006) ;32: 427-432.
. Jeune ML, Kumi-Diaka J, Brown J.
Anticancer activities of pomegranate
extracts and genistein in human breast
cancer cells. Journal of Medicinal Food
(2005);8: 469-475.
. Malikovia J, Swaczynova J, Kolar Z,
Strnad M. Anticancer and
antiproliferative activity of natural
brassinosteroids. Phytochemistry
(2007);69: 418-426.
. Natesan S, Badami S, Dongre SH,
Godavarthi A. Antitumor activity and
antioxidant status of the methanol
extract of Careya arborea bark against
Dalton’s lymphoma ascites induced
ascetic and solid tumor in mice. Journal
Pharmacological Science (2007) ;103:
-23.
. Rajkapoor B, Jayakar B, Murugesh N.
Antitumor activity of Indigofera
aspalathoides on Ehrlisch ascites
carcinoma in mice. Indian Journal of
Pharmacology (2004);36: 38-40.
. Shoemaker M, Hamilton B, Dairkee
SH, Cohen I, Campbell MJ. Invitro
anticancer activity of twelve Chinese
medicinal herbs. Phytotherapy
Research (2005);19: 649-651.
. Dongre SH, Badami S, Godavarthi A.
Antitumor activity of Hypericum
hookeranium against DLA induced
tumor in mice and its possible
mechanism of action. Phytotherapy
Research (2008);22: 23-29.
. Badisa RB, Badisa VL, Walker EH,
Latinwo LM. Potent cytotoxic activity of
Saururus cernuus on human colon and
breast carcinoma cultures under
normoxic conditions. Anticancer
Research (2007);27: 189-193.
. Faried A, Kurnia D, Faried LS, Usman
N, Miyazaki T . Anticancer effects of
gallic acid isolated from Indonesian
herbal medicine, Phaleria macrocarpa
Boerl, on human cancer cell lines.
International Journal of Oncology
(2007);30: 605-614.
. Shukla Y, Singh M. Cancer preventive
properties of ginger: a brief review.
Food and Chemical Toxicology (2007)
;45: 683-690.
. Amirghofran Z, Bahmani M, Azadmehr
A, Javidnia K. Anticancer effects of
various Iranian native medicinal on
human tumor cell lines.
Neoplasma(2005); 53: 428-433.
. Wang W, Zhao Y, Rayburn ER, Hill DL,
Wang H. Invitro anti-Cancer and
structure activity relationships of
natural products isolated from fruits of
Panax ginseng. Cancer Chemotherapy
in Pharmacology (2007);59: 589-601.
. Sullivan R, Smith JE, Rowan NJ.
Medicinal mushrooms and cancer
therapy: translating a traditional
practice in to western medicine.
Perspective Biology and Medicine
(2006);49: 159-170.
. Zhao Y, Wang CM, Wang BG, Zhang
CX. Study on the anticancer activities
of the Clematis manshrica saponins
invivo. China journal of Chinese
materia medica (2005);30: 1452-1453.
. Xu M, Cui J, Fu H, Proksch P, Lin W.
Embelin derivatives and their
anticancer activity through microtubule
disassembly. Planta Medicina (2005)
;71: 944-948.
. Modzelewska A, Sur S, Kumar SK,
Khan SR. Sesquiterpenes: natural
products that decrease cancer growth.
Current Medicinal Chemistry
Anticancer Agents (2005);5: 477-499.
. Lee JY, Hwang WI, Lim ST.
Antioxidant and anticancer activities of
organic extracts from platycodon
grandiflorum A De candolle roots.
Journal of Ethonopharmacology (2004)
;93: 409-415.
. Rosangkima G, Prasad SB.
Antitumour activity of some plants from
meghalaya and mizoram against
murine ascites dalton's lymphoma.
Indian Journal of Experimental Biology
(2004) ;42: 981-988.
. Amin A, Gali-Muhtasib H, Ocker M,
Schneider-Stock R. Overview of Major
Classes of Plant-Derived Anticancer
Drugs. International Journal in
Biomedical Science; (2009).;5: 1–11.
. Zhou S, Lim LY, Chowbay B. Herbal
modulation of P-glycoprotein. Drug
Metabolism(2017); 36: 57-104.
. Beijnen JH, Vendrig DE, Underberg
WJ. Stability of vinca alkaloid
anticancer drugs in three commonly
used infusion fluids. Journal Parenteral
Science Technology (1989); 43: 84-87.
. Gralla RJ, Gatzemeier U, Gebbia V,
Huber R, O’Brien M, Puozzo C. Oral
vinorelbine in the treatment of nonsmall cell lung cancer: rationale and
implications for patient management.
Drugs(2007); 67: 1403-1410.
. Baldwin EL, Osheroff N. Etoposide,
topoisomerase II and cancer. Current
Medicinal Chemistry Anticancer
Agents(2005); 5: 363-372.
. Kjeldsen E, Svejstrup JQ, Gromova II,
Alsner J, Westergaard O.
Camptothecin inhibits both the
cleavage and religation reactions of
eukaryotic DNA topoisomerase.
International Journal of Molecular
Biology; (1992);228: 1025-1030.
. Itokawa H, Ibraheim ZZ, Ya FQ,
Takeya K. Anthraquinones,
naphthohydroquinones and
naphthohydroquinone dimmers from
Rubia cordifolia and their cytotoxic
activity. Chemical and Pharmaceutical
Bulletin; (1993);41: 1869-1872.
. Lü S, Wang J. Homoharringtonine and
omacetaxine for myeloid hematological
malignancies. Journal of Hematology
and Oncology; (2014); 7: 2.
. Srivastava SK, Jha A, Agarwal SK,
Mukherjee R, Burman AC. Synthesis
and structure-activity relationships of
potent antitumor active quinoline and
naphthyridine derivatives. Anticancer
Agents in Medicinal Chemistry;
(2007);7: 685-709.
. Panda D, Miller HP, Islam K, Wilson L.
Stabilization of microtubule dynamics
by estramustine by binding to a novel
site in tubulin: A possible mechanistic
basis for its antitumor action.
Proceedings of the National Academic
Science USA (1997); 94: 10560–
. Newcomb EW. Flavopiridol pleiotropic
biological effects enhance its anticancer activity. Anticancer Drugs;
(2004);15: 411-419.
. Tozer GM, Kanthou C, Parkins CS, Hill
SA.The biology of the combretastatins
as tumour vascular targeting agents.
International Journal Experimental
Pathology (2002); 83: 21–38.
. Fulda S. Betulinic Acid for Cancer
Treatment and Prevention.
International Journal Molecular
Science; (2008);9: 1096–1107.
. Kim S, Hwang BY, Su BN, Chai H, Mi
Q, Kinghorn AD. Silvestrol, a potential
anticancer rocaglate derivative from
Aglaia foveolata, induces apoptosis in
LNCaP cells through the
mitochondrial/apoptosome pathway
without activation of executioner
caspase-3 or -7. Anticancer Research;
(2007);27: 2175-2183.
. Holkova B, Perkins BE, Ramakrishnan
V, Tombes MB, Shrader E, Talreja N.
Phase I Trial of Bortezomib (PS-341;
NSC 681239) and Alvocidib
(Flavopiridol; NSC 649890) in Patients
with Recurrent or Refractory B-cell
Neoplasms. Clinical Cancer Research;
(2011);17: 3388–3397.
. Pan L, Chai H, Kinghorn AD. The
continuing search for antitumor agents
from higher plants. Phytochemistry
Letters; (2010);3: 1–8.
. Boopathy NS, Kathiresan K. Anticancer
Drugs from Marine Flora: An Overview.
Journal of Oncology; (2010); 1-18.
. Hussain H, Krohn K, Ahmad VU,
Miana GA, Green IR. Lapachol: an
overview. ARKIVOC(2007); 2: 145-171.
. Popoca J, Aguilar A, Alonso D,
Villarreal ML. Cytotoxic activity of
selected plants used as antitumorals in
Mexican traditional medicine. Journal
of Ethnopharmacology (1998); 59:173-
. Ljubuncic P, Azaizeh H, Portnaya I,
Cogan U, Said O, Saleh KA.
Antioxidant activity and cytotoxicity of
eight plants used in traditional Arab
medicine in Israel. Journal of
Ethnopharmacology; (2005);99: 43-47.
. Shen T, Wan W, Yuan H, Kong F, Guo
H, Fan P. Secondary metabolites from
Commiphora opobalsamum and their
antiproliferative effect on human
prostate cancer cells. Phytochemistry;
(2007).;68: 1331-1337.
. Pal A, Ganguly A, Ghosh A, Yousuf M,
Rathore B, Banerjee R. Bis-arylidene
oxindoles as anti-breast-cancer agents
acting via the estrogen receptor.
Medicinal Chemistry; (2014);9: 727-
. Li FR, Jiao P, Yao ST, Sang H, Qin
SC, Zhang W. Paris polyphylla Smith
extract induces apoptosis and activates
cancer suppressor gene connexin26
expression. Asian Pacific Journal in
Cancer Prevention; (2012);13: 205-
. Sertel S, Eichhorn T, Plinkert PK,
Efferth T. Anticancer activity of Salvia
officinalis essential oil against HNSCC
cell line (UMSCC1). HNO (2011); 59:
-1208.
. Ghosh S, Das Sarma M, Patra A,
Hazra B. Anti-inflammatory and
anticancer compounds isolated from
Ventilago madraspatana Gaertn, Rubia
cordifolia Linn. and Lantana camara
Linn. Journal Pharmacy and
Pharmacology; (2010);62: 1158-1166.
. An L, Tang JT, Liu XM, Gao NN,
Zhongguo Zhong Yao Za Zhi. Review
about mechanisms of anti-cancer of
Solanum nigrum (2006);31: 1225-1226.
. Gatouillat G, Magid AA, Bertin E,
Okiemy-Akeli MG, Morjani H, Lavaud
C. Cytotoxicity and apoptosis induced
by alfalfa (Medicago sativa) leaf
extracts in sensitive and multidrugresistant tumor cells. Nutrition and
Cancer
; (2014); 66: 483-491.
. Saxena RB. Botany, Taxonomy and
Cytology of Crocus sativus series.
Ayurvedic (2010); 31: 374–381.
. Lee HJ, Lee HJ, Magesh V, Nam D,
Lee EO, Ahn KS. Shikonin,
acetylshikonin, and isobutyroylshikonin
inhibit VEGF-induced angiogenesis
and suppress tumor growth in lewis
lung carcinoma-bearing mice (2008);
: 1681-1688.
. Sarkar FH, Li Y, Wang Z, Kong D. The
role of nutraceuticals in the regulation
of Wnt and Hedgehog signaling in
cancer. Cancer Metastasis Reviews;
(2010);29: 383–394.
. Murillo G, Mehta RG. Cruciferous
vegetables and cancer prevention.
Nutrition and Cancer (2001); 41: 17-28.
. Darvesh AS, Bishayee A.
Chemopreventive and therapeutic
potential of tea polyphenols in
hepatocellular cancer. Nutrition and
Cancer (2013);65: 329-344.
. Son H, Chung M, Lee SIK, Yang HD,
Moon HI. Pomiferin, histone
deacetylase inhibitor isolated from the
fruits of Maclura pomifera. Bioorganic &
Medicinal Chemistry Letters (2007);
: 4753–4755.
. Sarkar FH, Li Y. Soy isoflavones and
cancer prevention. Cancer
Investigation (2003);21: 744-757.
.Ghosheh OA, Houdi AA, Crooks PA.
Analysis of the pharmacologically
active quinones and related
compounds in the oil of the black seed
(Nigella sativa L.) Journal of
Pharmaceutical Biomedical Science;
(1999);19: 757–762.
. Einbond LS, Soffritti M, Esposti DD,
Park T, Cruz E, Su T. Actein activates
stress- and statin-associated
responses and is bioavailable in
Sprague-Dawley rats. Fundamentals in
Clinical Pharmacology (2009);23: 311-
. Thomson M, Ali M. [Allium sativum]: a
review of its potential use as an
anticancer agent. Current Cancer Drug
Targets (2003);Garlic 3: 67-81.
. Rajagopal S, Kumar RA, Deevi DS,
Satyanarayana C, Rajagopalan R.
Andrographolide, a potential cancer
therapeutic agent isolated from
Andrographis paniculata. Journal
Experimental Therapy Oncology;
(2003); 3: 147-158.
. Yao C, Jin CL, Oh JH, Oh IG, Park CH,
Chung JH. Ardisia crenata extract
stimulates melanogenesis in B16F10
melanoma cells through inhibiting
ERK1/2 and Akt activation. Molecular
Medicine Reports. 2015; 11: 653-657.
. Zhang YS, Xie JZ, Zhong JL, Li YY,
Wang RQ, Qin YZ. Acetyl-11-keto- β-
boswellic acid (AKBA) inhibits human
gastric carcinoma growth through
modulation of the Wnt/β-catenin
signaling pathway. Biochim Biophys
Acta; (2013);1830: 3604-3615.
. Lee YS, Jin DQ, Kwon EJ, Park SH,
Lee ES, Jeong TC. Asiatic acid, a
triterpene, induces apoptosis through
intracellular Ca2+ release and
enhanced expression of p53 in HepG2
human hepatoma cells. Cancer Letters;
(2002);186: 83–91.
. Bar-Sela G, Epelbaum R, Schaffer M.
Curcumin as an anti-cancer agent:
review of the gap between basic and
clinical applications. Current Medicinal
Chemistry; (2010); 17: 190-197.
. Kang JH, Song KH, Woo JK, Park MH,
Rhee MH, Choi C. Ginsenoside Rp1
from Panax ginseng exhibits anticancer activity by down-regulation of
the IGF-1R/Akt pathway in breast
cancer cells, Plant Foods Human
Nutrition (2011);66: 298-305.
. Yan W, Wang TY, Fan QM, Du L, Xu
JK, Zhai ZJ. Plumbagin attenuates
cancer cell growth and osteoclast
formation in the bone
microenvironment of mice. Acta
Pharmacol Sin (2014); 35: 124-134.
. Nie D, Krishnamoorthy S, Jin R, Tang
K, Chen Y, Qiao Y. Mechanisms
regulating tumor angiogenesis by 12-
lipoxygenase in prostate cancer cells.
Journal of Biological Chemistry; .
(2006);281:18601-18609.
. Poeta MD, Chen SF, Hoff DV, Dykstra
CC, Wani MC, Manikumar G.
Comparison of In Vitro Activities of
Camptothecin and Nitidine Derivatives
against Fungal and Cancer Cells.
Antimicrobial Agents Chemotherapy;
(1999);43: 2862–2868.
. Kruczynski A, Etiévant C, Perrin D,
Chansard N, Duflos A, Hill BT.
Characterization of cell death induced
by vinflunine, the most recent Vinca
alkaloid in clinical development. British
Journal of Cancer
; (2002); 86: 143–
. Abou-Alfa GK, Letourneau R, Harker
G, Modiano M, Hurwitz H,
Tchekmedyian NS. Randomized phase
III study of exatecan and gemcitabine
compared with gemcitabine alone in
untreated advanced pancreatic cancer.
Journal of Clinical Oncology;
(2006);24: 4441-4447.
